MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,719,000 | +49.7% | 111,768 | +22.4% | 0.14% | +26.8% |
| Q1 2020 | $2,484,000 | -12.2% | 91,316 | -40.3% | 0.11% | +10.9% |
| Q3 2017 | $2,829,000 | +9.5% | 152,900 | 0.0% | 0.10% | +5.2% |
| Q2 2017 | $2,584,000 | -61.6% | 152,900 | -69.7% | 0.10% | -63.2% |
| Q1 2017 | $6,734,000 | +45.9% | 504,400 | +64.5% | 0.26% | +32.5% |
| Q4 2016 | $4,614,000 | +156.8% | 306,600 | +99.5% | 0.20% | +185.5% |
| Q3 2016 | $1,797,000 | +8.3% | 153,700 | 0.0% | 0.07% | +1.5% |
| Q2 2016 | $1,660,000 | +16.9% | 153,700 | 0.0% | 0.07% | +13.3% |
| Q1 2016 | $1,420,000 | -37.7% | 153,700 | 0.0% | 0.06% | -27.7% |
| Q4 2015 | $2,281,000 | -9.6% | 153,700 | 0.0% | 0.08% | -8.8% |
| Q3 2015 | $2,522,000 | -53.1% | 153,700 | -56.5% | 0.09% | -57.3% |
| Q1 2015 | $5,374,000 | -58.2% | 353,575 | -66.9% | 0.21% | -64.6% |
| Q4 2014 | $12,854,000 | +6.2% | 1,067,575 | 0.0% | 0.60% | +6.2% |
| Q3 2014 | $12,106,000 | +183.5% | 1,067,575 | +202.0% | 0.57% | +44.6% |
| Q2 2014 | $4,270,000 | – | 353,475 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |